These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 3416660

  • 1. In vitro activity of A-56619 and A-56620 against multi-resistant and routine clinical isolates.
    Fernandes CJ, Wilson RD, Ackerman VP.
    Chemotherapy; 1988; 34(3):216-28. PubMed ID: 3416660
    [Abstract] [Full Text] [Related]

  • 2. In vitro activity of trovafloxacin (CP 99,219), a new fluoroquinolone against hospital isolates.
    Ling TK, Liu EY, Cheng AF.
    Chemotherapy; 1999; 45(1):22-7. PubMed ID: 9876206
    [Abstract] [Full Text] [Related]

  • 3. The comparative activity of fleroxacin, three other quinolones and eight unrelated antimicrobial agents.
    McCarter YS, Mazens-Sullivan MF, Bartlett RC.
    Chemotherapy; 1992; 38(5):308-18. PubMed ID: 1337507
    [Abstract] [Full Text] [Related]

  • 4. In vitro activity of fleroxacin (Ro23-6240), a new fluorinated 4-quinolone against isolates from cancer patients.
    Rolston K, Ho DH, LeBlanc B, Bodey GP.
    Chemotherapy; 1988; 34(6):448-54. PubMed ID: 3149568
    [Abstract] [Full Text] [Related]

  • 5. In-vitro activity of Sch 34343, a new penam, against gram-positive isolates from cancer patients.
    Rolston KV, Alvarez ME, Hoy JF, Alderman HC, Ho DH, Bodey GP.
    J Antimicrob Chemother; 1986 Aug; 18(2):159-62. PubMed ID: 3093447
    [Abstract] [Full Text] [Related]

  • 6. In vitro activity of cefpirome (HR810) against antibiotic-resistant gram-positive and gram-negative bacteria including organisms with inducible resistance.
    Murray PR, Niles AC.
    Diagn Microbiol Infect Dis; 1986 Jan; 4(1):53-63. PubMed ID: 3632921
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vitro activity of PD127,391, a new quinolone against bacterial isolates from cancer patients.
    Rolston KV, Ho DH, LeBlanc B, Bodey GP.
    Chemotherapy; 1990 Jan; 36(5):365-72. PubMed ID: 2209169
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. In vitro activity of BAY 12-8039, a new 8-methoxyquinolone.
    Dalhoff A, Petersen U, Endermann R.
    Chemotherapy; 1996 Jan; 42(6):410-25. PubMed ID: 8957575
    [Abstract] [Full Text] [Related]

  • 12. In vitro activity of SCH-34343, a new penam, and other antimicrobial agents against clinical isolates from cancer patients.
    Rolston KV, Alvarez ME, Hoy JF, Alderman HC, Ho DH, Bodey GP.
    Chemotherapy; 1986 Jan; 32(6):506-14. PubMed ID: 3100147
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In vitro activity of temafloxacin, a new difluoro quinolone antimicrobial agent.
    Chin NX, Figueredo VM, Novelli A, Neu HC.
    Eur J Clin Microbiol Infect Dis; 1988 Feb; 7(1):58-63. PubMed ID: 3132380
    [Abstract] [Full Text] [Related]

  • 18. In vitro activity of A-56619 and A56620, two new aryl-fluoroquinolone antimicrobial agents.
    Smith BR, LeFrock JL, Donato JB, Joseph WS, Weber SJ.
    Antimicrob Agents Chemother; 1986 Feb; 29(2):355-8. PubMed ID: 3717937
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.